Renaissance Technologies - TRACON PHARMACEUTICALS INC ownership

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 34 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$129
+658.8%
300,238
+206.2%
0.00%
Q4 2023$17
-29.2%
98,038
-27.1%
0.00%
Q3 2023$24
-42.9%
134,538
-6.2%
0.00%
Q2 2023$42
-86.8%
143,484
-14.9%
0.00%
Q1 2023$319
+58.7%
168,600
+24.8%
0.00%
Q4 2022$201
-99.8%
135,049
+98.9%
0.00%
Q3 2022$113,000
+7.6%
67,900
+29.1%
0.00%
Q2 2022$105,000
+36.4%
52,600
+80.1%
0.00%
Q1 2022$77,000
-86.8%
29,200
-86.2%
0.00%
-100.0%
Q4 2021$584,000
-50.8%
211,000
-31.3%
0.00%
-50.0%
Q3 2021$1,188,000
+5.5%
306,976
+76.9%
0.00%
+100.0%
Q2 2021$1,126,000
-43.1%
173,535
-27.9%
0.00%
-50.0%
Q1 2021$1,980,000
+0.1%
240,600
+42.3%
0.00%0.0%
Q4 2020$1,978,000
+369.8%
169,100
+107.5%
0.00%
Q3 2020$421,000
-22.6%
81,500
-70.6%
0.00%
Q2 2020$544,000
+38.1%
277,396
+19.7%
0.00%
Q1 2020$394,000
+11.0%
231,729
+52.9%
0.00%
Q4 2019$355,000151,5290.00%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,013,438$10,409,0002.04%
Ikarian Capital, LLC 2,162,549$11,180,0000.81%
Telemetry Investments, L.L.C. 54,723$283,0000.62%
Vigilare Wealth Management 17,000$88,0000.09%
Johnson & Johnson Innovation - JJDC, Inc. 84,003$434,0000.09%
NEA Management Company, LLC 346,718$1,793,0000.08%
BOOTHBAY FUND MANAGEMENT, LLC 236,301$1,222,0000.07%
GSA CAPITAL PARTNERS LLP 81,675$422,0000.07%
Virtu Financial LLC 61,180$316,0000.05%
683 Capital Management, LLC 75,000$388,0000.03%
View complete list of TRACON PHARMACEUTICALS INC shareholders